Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Mirei, Horiuchi"'
Autor:
Masahiro Yoshida, Yosuke Nakaya, Katsujun Shimizu, Naoko Tatsumi, Minako Tsutsumi, Hoyuri Fuseya, Mirei Horiuchi, Takuro Yoshimura, Yoshiki Hayashi, Takafumi Nakao, Takeshi Inoue, Takahisa Yamane
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Abstract Treatment of patients with malignancy sometimes be delayed due to various reasons. Several studies revealed that an influence of diagnosis-to-treatment interval (DTI) on outcomes differs depending on the type of malignancy. In this study, we
Externí odkaz:
https://doaj.org/article/4bc35587960143248af35001577f9702
Autor:
Hoyuri Fuseya, Takuro Yoshimura, Minako Tsutsumi, Yosuke Nakaya, Mirei Horiuchi, Masahiro Yoshida, Yoshiki Hayashi, Takafumi Nakao, Takeshi Inoue, Takahisa Yamane
Publikováno v:
Clinical Case Reports, Vol 9, Iss 8, Pp n/a-n/a (2021)
Abstract Although effective combination of antiretroviral medications is being developed, the incidence of non‐Hodgkin lymphoma (NHL) with human immunodeficiency/acquired immunodeficiency syndrome (HIV/AIDS) still remains significantly higher than
Externí odkaz:
https://doaj.org/article/f561c0abae78415d8875069d3ba5b34c
Autor:
Yusuke Okayama, Teruhito Takakuwa, Ippei Otomaru, Mirei Horiuchi, Akiko Miura, Taku Araki, Yotaro Fujitani, Ryosuke Yamamura
Publikováno v:
Clinical Case Reports, Vol 9, Iss 5, Pp n/a-n/a (2021)
Abstract Low‐dose imatinib with monitoring of drug concentrations in blood may successfully control Philadelphia chromosome‐positive mixed phenotype acute leukemia (Ph+MPAL), particularly in elderly patients with comorbidities.
Externí odkaz:
https://doaj.org/article/f6bb22bb0ef445e9babc5642f9ac25c8
Autor:
Katsujun Shimizu, Yosuke Nakaya, Takahisa Yamane, Minako Tsutsumi, Takuro Yoshimura, Takeshi Inoue, Takafumi Nakao, Mirei Horiuchi, Naoko Yagi, Yoshiki Hayashi, Hoyuri Fuseya, Masahiro Yoshida
Publikováno v:
International Journal of Hematology. 112:741-745
Hyperviscosity syndrome (HVS) can cause multiple organ damage if not treated immediately. IgM multiple myeloma (IgM MM) is a very rare form of myeloma with clinical features such as elevated serum IgM, and anemia, that resemble Waldenström macroglob
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ca96bf8e139f138669d14dcb7ce00748
https://doi.org/10.1007/s12185-020-02917-7
https://doi.org/10.1007/s12185-020-02917-7
Autor:
Takuro Yoshimura, Takeshi Inoue, Takahisa Yamane, Naoko Tatsumi, Yosuke Nakaya, Minako Tsutsumi, Mirei Horiuchi, Masahiro Yoshida, Takafumi Nakao, Yoshiki Hayashi, Hoyuri Fuseya
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 20:e291-e294
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2724d8a1fdef1e0023f944f505f67d67
https://doi.org/10.1016/j.clml.2019.12.020
https://doi.org/10.1016/j.clml.2019.12.020
Autor:
Takahisa Yamane, Minako Tsutsumi, Mirei Horiuchi, Yosuke Nakaya, Takuro Yoshimura, Takafumi Nakao, Takeshi Inoue, Masahiro Yoshida, Yoshiki Hayashi, Hoyuri Fuseya
Publikováno v:
Clinical Case Reports
Although effective combination of antiretroviral medications is being developed, the incidence of non‐Hodgkin lymphoma (NHL) with human immunodeficiency/acquired immunodeficiency syndrome (HIV/AIDS) still remains significantly higher than that in i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::09eece3096ad9a2bf944896ebf69aa3f
http://europepmc.org/articles/PMC8385253
http://europepmc.org/articles/PMC8385253
Autor:
Yoshiki Hayashi, Hoyuri Fuseya, Masahiro Yoshida, Takafumi Nakao, Mirei Horiuchi, Ryoko Sakagami, Takane Aoyama, Yosuke Nakaya, Takuro Yoshimura, Takahisa Yamane, Naoko Tatsumi, Kai Yamasaki, Minako Tsutsumi
Publikováno v:
Annals of Hematology. 100:1329-1331
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9248b7b005eb77bd51c21535fec06894
https://doi.org/10.1007/s00277-020-04332-8
https://doi.org/10.1007/s00277-020-04332-8
Autor:
Yusuke, Okayama, Teruhito, Takakuwa, Ippei, Otomaru, Mirei, Horiuchi, Akiko, Miura, Taku, Araki, Yotaro, Fujitani, Ryosuke, Yamamura
Publikováno v:
Gan to kagaku ryoho. Cancerchemotherapy. 48(6)
In elderly patients aged≥80 with newly diagnosed multiple myeloma(NDMM), the optimal initial doses of bortezomib (Bor)and lenalidomide(Len)remain unclear. We performed a retrospective analysis that included 20 patients with NDMM aged≥80 years who
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::884908023dc62f1f9adf32d38106fc78
https://pubmed.ncbi.nlm.nih.gov/34139730
https://pubmed.ncbi.nlm.nih.gov/34139730
Autor:
Ryosuke Yamamura, Yotaro Fujitani, Akiko Miura, Taku Araki, Mirei Horiuchi, Teruhito Takakuwa, Ippei Otomaru, Yusuke Okayama
Publikováno v:
Clinical Case Reports
Clinical Case Reports, Vol 9, Iss 5, Pp n/a-n/a (2021)
Clinical Case Reports, Vol 9, Iss 5, Pp n/a-n/a (2021)
Low‐dose imatinib with monitoring of drug concentrations in blood may successfully control Philadelphia chromosome‐positive mixed phenotype acute leukemia (Ph+MPAL), particularly in elderly patients with comorbidities.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a13fca4c29acfa6907246ea9cd325808
http://europepmc.org/articles/PMC8123726
http://europepmc.org/articles/PMC8123726
Autor:
Katsujun Shimizu, Masahiro Yoshida, Mirei Horiuchi, Yoshiki Hayashi, Hoyuri Fuseya, Minako Tsutsumi, Takeshi Inoue, Takafumi Nakao, Takuro Yoshimura, Yosuke Nakaya, Takahisa Yamane, Naoko Tatsumi
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-7 (2021)
Scientific Reports
Scientific Reports
Treatment of patients with malignancy sometimes be delayed due to various reasons. Several studies revealed that an influence of diagnosis-to-treatment interval (DTI) on outcomes differs depending on the type of malignancy. In this study, we evaluate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::97eda5043335ae3f8d2fe3c07ad81cc6
https://doi.org/10.1038/s41598-021-82615-4
https://doi.org/10.1038/s41598-021-82615-4